| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 15.870 | 58.298 | 134.792 | 215.346 |
| Total Income - EUR | - | - | - | - | - | - | 15.879 | 58.347 | 134.796 | 215.351 |
| Total Expenses - EUR | - | - | - | - | - | - | 12.185 | 50.140 | 105.005 | 172.706 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 3.694 | 8.207 | 29.791 | 42.645 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 3.227 | 7.694 | 28.645 | 37.823 |
| Employees | - | - | - | - | - | - | 0 | 1 | 1 | 2 |
Check the financial reports for the company - Podocare Efect S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 66 | 1.740 | 1.221 | 7.584 |
| Current Assets | - | - | - | - | - | - | 7.907 | 15.423 | 39.043 | 78.012 |
| Inventories | - | - | - | - | - | - | 4.049 | 12.043 | 15.753 | 35.552 |
| Receivables | - | - | - | - | - | - | 2.549 | 1.530 | 16.307 | 17.518 |
| Cash | - | - | - | - | - | - | 1.309 | 1.850 | 6.983 | 24.941 |
| Shareholders Funds | - | - | - | - | - | - | 3.267 | 10.972 | 39.584 | 77.185 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 4.717 | 6.201 | 680 | 8.410 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4774 - 4774" | |||||||||
| CAEN Financial Year |
4774
|
|||||||||
Comments - Podocare Efect S.r.l.